T1	p 28 52	advanced breast cancer .
T2	p 282 324	of advanced breast cancers which they have
T3	p 376 436	departments of medicine in eight French anticancer centres .
T4	p 516 520	work
T5	p 585 597	603 patients
T6	p 839 863	doxorubicine or/and with
T7	p 1136 1139	240
T8	i 12 24	chemotherapy
T9	i 241 262	programme evolved for
T10	i 698 710	chemotherapy
T11	i 717 752	consisted of vincristine associated
T12	i 775 811	cyclophosphamide and 5-fluoro-uracil
T13	i 839 878	doxorubicine or/and with methotrexate .
T14	i 931 957	therapy using doxorubicine
T15	i 1368 1380	chemotherapy
T16	i 1422 1432	anticancer
T17	o 521 522	.
T18	o 981 990	frequency
T19	o 1271 1281	palliation
T20	o 1288 1292	cure